Reproductive outcome in patients with diminished ovarian reserve

被引:237
作者
Levi, AJ
Raynault, MF
Bergh, PA
Drews, MR
Miller, BT
Scott, RT
机构
[1] Reprod Med Associates New Jersey, Morristown, NJ 07962 USA
[2] NICHHD, Pediat & Reprod Endocrinol Branch, NIH, Bethesda, MD 20892 USA
[3] St Barnabus Med Ctr, Inst Reprod Med & Sci, Livingston, NJ USA
关键词
diminished ovarian reserve; basal follicle-stimulating hormone; pregnancy loss; live birth;
D O I
10.1016/S0015-0282(01)02017-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare reproductive outcome between women with normal ovarian reserve and women with abnormal ovarian reserve. Design: Retrospective. Setting: Tertiary care center. Patient(s): Nine thousand eight hundred and two patients who had basal follicle-stimulating hormone (FSH) concentrations measured as part of an infertility evaluation. Intervention(s): Monitoring of early pregnancy. Main Outcome Measure(s): Pregnancy loss rates, live birth rates. Result(s): Of 1,034 patients with diminished ovarian reserve (DOR) (FSH greater than or equal to 14.2 IU/L), 28 (2.7%) conceived. Twenty of these pregnancies (20/28; 71.4%) were lost in the first trimester. Pregnancy loss rates in women with DOR were 57.1% in women <35 years old, 63.5% in women 35-40 years old, and 90.0% in women >40 years old. These rates of pregnancy loss were significantly higher compared to age-matched patients with normal ovarian reserve. Conclusion(s): Women with DOR have exceedingly high rates of pregnancy loss, regardless of age. Women with diminished ovarian reserve should be counseled that, in addition to a low probability of conception, live birth rates are poor. (Fertil Steril(R) 2001;76:666-9. (C) 2001 by American Society for Reproductive Medicine.).
引用
收藏
页码:666 / 669
页数:4
相关论文
共 15 条
[1]  
Battaglia DE, 1996, HUM REPROD, V11, P2217
[2]   Recurrent pregnancy loss and diminished ovarian reserve [J].
Hofmann, GE ;
Khoury, J ;
Thie, J .
FERTILITY AND STERILITY, 2000, 74 (06) :1192-1195
[3]  
LOUMAYE E, 1990, FERTIL STERIL, V53, P295
[4]   Incidence of chromosomal abnormalities from a morphologically normal cohort of embryos in poor-prognosis patients [J].
Magli, MC ;
Gianaroli, L ;
Munne, S ;
Ferraretti, AP .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1998, 15 (05) :297-301
[5]   EMBRYO MORPHOLOGY, DEVELOPMENTAL RATES, AND MATERNAL AGE ARE CORRELATED WITH CHROMOSOME-ABNORMALITIES [J].
MUNNE, S ;
ALIKANI, M ;
TOMKIN, G ;
GRIFO, J ;
COHEN, J .
FERTILITY AND STERILITY, 1995, 64 (02) :382-391
[6]   Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy [J].
Nasseri, A ;
Mukherjee, T ;
Grifo, JA ;
Noyes, N ;
Krey, L ;
Copperman, AB .
FERTILITY AND STERILITY, 1999, 71 (04) :715-718
[7]  
Navot D, 1987, LANCET, V19, P45
[8]  
SCOTT RT, 1989, FERTIL STERIL, V51, P651
[9]  
SCOTT RT, 1995, FERTIL STERIL, V63, P1
[10]   Apoptosis as a function of ovarian reserve in women undergoing in vitro fertilization [J].
Seifer, DB ;
Gardiner, AC ;
Ferreira, KA ;
Peluso, JJ .
FERTILITY AND STERILITY, 1996, 66 (04) :593-598